Ifamọ ibatan: 96.97% (95% CI: 83.35%～99.99%)
Ojulumo pato: 100.00% (95% CI: 97.29%～100.00%)
Yiye: 99.50% (95% CI:96.94%～99.99%)
Awọn abajade iyara ni iṣẹju 15-30 Ohun elo antijeni iyara AMRDT120
Idanwo iyara fun wiwa didara ti didoju
awọn ọlọjẹ si SARS-CoV-2 tabi awọn ajesara rẹ ni gbogbo ẹjẹ, omi ara, tabi pilasima.
Package Specification: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.
Ifamọ ibatan: 96.97% (95% CI: 83.35%～99.99%)
Ojulumo pato: 100.00% (95% CI: 97.29%～100.00%)
Yiye: 99.50% (95% CI:96.94%～99.99%)
Awọn apo kekere, pẹlu awọn kasẹti idanwo ati awọn apọn * 20
Assay saarin * 20 lẹgbẹrun;
Isọnu droppers * 20;
Lancet *20
Lodine swab * 20
Ilana fun lilo * 1
Awọn abajade iyara ni iṣẹju 15-30 Ohun elo antijeni iyara AMRDT120 LILO
Igbeyewo Idaduro Antibody Rapid SARS-CoV-2 (COVID-19 Ab) jẹ ajẹsara chromatographic iyara fun wiwa didara ti didoju awọn ọlọjẹ si SARS-CoV-2 ni gbogbo ẹjẹ, omi ara, tabi pilasima.
Awọn abajade iyara ni iṣẹju 15-30 Ohun elo antijeni iyara AMRDT120 PRINCIPLE
Igbeyewo iyara Antibody ti SARS-CoV-2 Neutralizing (COVID-19 Ab) wa fun awọn ọlọjẹ wiwa si SARS-CoV-2 tabi awọn ajesara rẹ.Awọn olugba dada sẹẹli angiotensin iyipada henensiamu-2 (ACE2) ni a bo ni agbegbe laini idanwo ati agbegbe abuda olugba olugba (RBD) ti o ni idapọ pẹlu awọn patikulu itọkasi.
Lakoko idanwo, ti o ba jẹ pe awọn ọlọjẹ imukuro SARS-CoV-2 wa ninu apẹrẹ naa, yoo fesi pẹlu amuaradagba RBD-patiku conjugate ati pe ko fesi pẹlu amuaradagba ti a bo tẹlẹ ACE2.Adalu naa yoo lọ si oke lori awọ ara ilu chromatographically nipasẹ iṣe capillary ati pe kii yoo gba nipasẹ antijeni ti a bo tẹlẹ.Idanwo Rapid Antibody SARS-CoV-2 Neutralizing (COVID-19 Ab) ni awọn patikulu ti a bo RBD amuaradagba.Awọn amuaradagba ACE2 ni a bo ni agbegbe laini idanwo.
